GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Price-to-Owner-Earnings

4basebio (LSE:4BB) Price-to-Owner-Earnings : (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Price-to-Owner-Earnings?

As of today (2024-06-05), 4basebio's share price is £14.00. 4basebio does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for 4basebio's Price-to-Owner-Earnings or its related term are showing as below:


LSE:4BB's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.78
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-05), 4basebio's share price is £14.00. 4basebio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.51. Therefore, 4basebio's PE Ratio for today is At Loss.

As of today (2024-06-05), 4basebio's share price is £14.00. 4basebio's EPS without NRI for the trailing twelve months (TTM) ended in was £-0.51. Therefore, 4basebio's PE Ratio without NRI for today is At Loss.


4basebio Price-to-Owner-Earnings Historical Data

The historical data trend for 4basebio's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Price-to-Owner-Earnings Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
- - - -

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of 4basebio's Price-to-Owner-Earnings

For the Biotechnology subindustry, 4basebio's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4basebio's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where 4basebio's Price-to-Owner-Earnings falls into.



4basebio Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

4basebio's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=14.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4basebio  (LSE:4BB) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


4basebio Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of 4basebio's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


4basebio (LSE:4BB) Business Description

Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines